Capstone Investment Advisors, LLC Clovis Oncology, Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $226,069 - $485,980	-47,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $90,860 - $141,020	22,000 Added 88.0%	47,000 $226,000
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $75,000 - $410,750	25,000 New	25,000 $261,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $576,450 - $1.16 Million	-45,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $794,700 - $1.36 Million	45,000 New	45,000 $1.12 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.